Local recommendations (Nervous system)
For DMARD Shared Care click here
Antidepressants
Recommendation | Approval date | Review date |
Specialist Initiated Drugs Prescribing Information Sheet Bupropion EKPG | May 2018 | May 2021 |
Patient information - changes to Trimipramine prescribing | April 2021 | |
Trimipramine Audit - Patient information about reducing dose | April 2021 | |
Trimipramine Audit - Patient information about switching to Sertraline | April 2021 | |
Trimipramine Audit - Patient information about switching to Imipramine | April 2021 | |
Trimipramine PrescQIPP Information | April 2021 | |
Trimipramine briefing | April 2021 | |
East Kent CCGs Protocol for the Management of Long Term Mental Health Conditions in Primary Care | April 2021 | |
Vortioxetine Prescribing Guidelines - Feb 2019 | Feb 2019 | Feb 2022 |
Agomelatine Prescribing Guidelines | May 2019 | May 2022 |
Depression guidelines for primary care | April 2019 | April 2022 |
Anxiolytics, hypnotics and sedatives
Recommendation | Approval date | Review date |
Benzodiazepine and Z-hypnotic prescribing policy | June 2012 | April 2021 |
PR 2021-10: Melatonin for sleep disorders in children with neurodevelopmental disorders | August 2021 | August 2022 |
Chloral Hydrate in Children and Young People with Movement and Motor Disorders | April 2022 | April 2024 |
Kent and Medway Melatonin Guidance | December 2023 | December 2025 |
Melatonin Prescribing Checklist for Clinicians |
April 2024 | April 2026 |
Adult ADHD Prescribing
Recommendation | Approval date | Review date |
Adult ADHD Shared Care | December 2023 | December 2025 |
Dementia
Recommendation | Approval date | Review date |
BPSD Guidance for GPs | March 2022 | March 2024 |
K&M Dementia Medication Prescribing Guidance | October 2023 | October 2025 |
Epilepsy
Recommendation | Approval date | Review date |
Brivaracetam Information Sheet | December 2021 | December 2023 |
Buccal Midazolam for Patients with Epilepsy - EKPG Recommendation | June 2018 | June 2021 |
Eslicarbazepine Prescribing Guidelines - EKPG | September 2014 | April 2021 |
Lacosamide Prescribing Guidelines - EKPG | September 2014 | April 2021 |
Zonisamide Prescribing Guidelines - EKPG | September 2014 | April 2021 |
Kent and Medway Perampanel Prescribing Guidance | August 2022 | August 2024 |
Cenobamate Prescribing v1.3 | August 2022 | August 2024 |
Movement disorders - Dystonias and Parkinson's Disease
Recommendation | Approval date | Review date |
Botulinum toxin for masseteric hypertrophy, EKPG Recommendation | June 2016 | April 2021 |
Botulinum toxin for spasticity in adults, EKPG Recommendation | July 2016 | April 2021 |
Botulinum toxin type A for blepharospasm EKPG Recommendation | June 2015 | April 2021 |
Botulinum toxin type A for facial lines EKPG Recommendation | March 2016 | April 2021 |
EKPG Recommendation, Botulinum Toxin for Frey's syndrome | May 2016 | April 2021 |
EKPG Recommendation for Botulinum toxin for sialorrhoea in adults | September 2016 | April 2021 |
Shared Care Guideline Riluzole | May 2018 | May 2021 |
Co-careldopa intestinal gel (Duodopa) for the treatment of advanced Parkinsons disease EKPG | October 2013 | April 2021 |
Kent and Medway PRGC Policy Recommendation. Botulinum neurotoxin (BoNT) for the management of cervical dystonias and hemifacial spasms in adults PR 2021-22 | April 2022 | April 2024 |
Cannabis based medicinal products
Recommendation | Approval date | Review date |
Cannabis-based-medication-desk-guide | November 2018 | November 2021 |
Pain
Psychoses and related disorders
Recommendation | Approval date | Review date |
Quetiapine Prescribing Guidelines | February 2015 | April 2021 |
Minimum Physical Health Monitoring Requirements for Commonly Prescribed Psychotropic Medications | February 2017 | February 2020 |
Lithium Treatment Pathway | December 2022 | December 2024 |
Sleep disorders
Recommendation | Approval date | Review date |
Sodium oxybate for the treatment of narcolepsy with cataplexy in adults EKPG recommendation | January 2016 | April 2021 |
Substance dependence
Recommendation | Approval date | Review date |
Public Health services commissioned by KCC - Stop Smoking. Information for GP practices EKPG | February 2018 | February 2021 |
Headache and Migraine
Recommendation | Approval date | Review date |
Management of Adults with Headaches and Migraines in Primary Care | August 2022 | August 2024 |
Rimegepant for acute treatment of migraine – Guideline for Primary Care | June 2024 | June 2026 |